August 15, 2023
Rigaku is maintaining momentum in the field of electron diffraction (ED) and is proud to announce the sale of another XtaLAB Synergy-ED. The most recent sale will see a system installed at the University of Glasgow, where it will be a flagship instrument in a materials characterization analytical hub and serve researchers across the Scotland [...]
August 15, 2023
Version 2023 of the Classic pKa calculator in Percepta® includes a significantly expanded training set for improved prediction accuracy, broader chemical applicability, and algorithmic changes that deliver impressive speed enhancements to this industry-leading software. San Francisco, US —26 years after the release of their first ionization predictor, ACD/Labs, an informatics company that develops and commercializes software in support [...]
New T-Cell Killing Assay for Livecyte
August 14, 2023
Sheffield, UK, 14/08/2023 - Phasefocus, a pioneer in cutting-edge life science solutions, is pleased to announce its latest product, the Livecyte T-Cell Killing Assay, is launching on the 12th September 2023. This revolutionary new assay addresses key challenges faced by researchers in investigating the efficacy and cytotoxicity of engineered T-cells in killing target cancers. By [...]
August 14, 2023
Ten awardees to receive $5,000 and mentorship from Promega scientists Madison, WI USA. -- Ten undergraduate students will receive scholarships worth up to $5,000 and mentorship from established scientists in the biotechnology industry. The Diversification Of Our Research Scientists (D.O.O.R.S.) Scholarship aims to recognize and empower students from underrepresented backgrounds who are pursuing a biotechnology-related [...]
Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer
August 14, 2023
SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Gülsen Kama will serve as its next Chief Financial Officer (CFO), effective September 11, 2023. Christopher Stewart, who held the position of CFO since September 2020, will stay on during the transition and then move into an advisory role. Ms. Kama has an extensive background [...]
BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
August 14, 2023
MINNEAPOLIS -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that the company will end their collaboration with Akoya Biosciences to co-develop an automated RNAscope™ workflow for use with the PhenoCycler®-Fusion System. The decision was made following best efforts to achieve [...]
Curiox Biosystems Inc., Announces Initial Public Offering (IPO)
August 14, 2023
SEOUL, SOUTH KOREA — Curiox Biosystems Inc., a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, announced today the pricing of its initial public offering of 1,400,000 shares of its common stock at a price to the public of 13,000 won per share. Shares have started trading on the Korea [...]
Element Biosciences Establishes Scientific Advisory Board
August 14, 2023
Leading Scientists from Stanford, University of Chicago, and Wellcome Sanger Institute Strengthen Element’s R&D Expertise and Innovation Engine SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced the formation of its Scientific Advisory Board with four leading experts on genomics, oncology, chemistry, [...]
Thermo Fisher Scientific Completes Acquisition of CorEvitas
August 14, 2023
Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Share 1 WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed the acquisition of CorEvitas, LLC (“CorEvitas”), a leading provider of regulatory-grade, real-world evidence [...]
ArcticZymes Technologies launches AZtaq™ DNA Polymerase
August 10, 2023
Tromsø, Norway – ArcticZymes Technologies ASA (OSE: AZT) launches AZtaq™ DNA Polymerase. ArcticZymes Technologies (AZT) today announces the launch of its new product, AZtaq™ DNA Polymerase. AZtaq™ is a high-quality thermostable DNA polymerase suitable for use in polymerase chain reaction (PCR) applications. Launching the AZtaq™ is a natural expansion of the Company’s molecular tools portfolio. [...]

